Subject: Re: "How To Use" Instructions for CholesLo
From: [email-masked]
To: [email-masked], [email-masked]
Date: Mon, 21 Oct 2019 16:05:32 -0700

ZD#83716.

AJ
HFL Customer Support

----- Original Message -----
From:
 "Gino Piticco" <[email-masked]>

To:
"- Dr. Sam Robbins -" <[email-masked]>
Cc:

Sent:
Mon, 21 Oct 2019 19:00:17 -0400
Subject:
Re: "How To Use" Instructions for CholesLo

Thank you for your CholesLo response. 

You have your information wrong. 

I am not a first time user of CholesLo. 
Check your order records. I have been using 
your product for over the past five years. 

I am fully aware on how to use CholesLo 
thank you anyways. 

To let you know I have a problem with your 
Alpha Viril product. Since I purchased 
my last order from you of your Alpha Viril 
about 6 months ago every time I take one 
tablet as directed after about 45 minutes later my eyes 
become very red in colour. How you 
changed your ingredients make up 
in your product??  

I used this product 5 years ago and 
I never had any adverse reaction. Now 
It seems to give me red eyes for some 
reasons. Can you explain to me why 
this is happening. 

I await your response Dr. Sam. 

Gino 

Gino Piticco  BAA (PI)MDRT NQA
President 
Investment and Insurance Advisor
Supreme Financial Agency Ltd.

Office: (905) 762-0022  Ext-222
Fax: (905) 762-0023
Cell: (416) 457-4028

Office Address:
Supreme Financial Agency Ltd.
Gino Piticco Financial Advisor 
300 John Street, Suite 603
Thornhill, Ontario.
L3T-5W4

You received this communication because you have provided 
me with an electronic email address. If you do not 
wish to receive electronic communications from me please respond to
this email by typing "UNSUBSCRIBE" in the subject line of 

your email response. 
I will remove 
you from my distribution list.

On Oct 21, 2019, at 5:47 PM, - Dr. Sam Robbins - <[email-masked]
[1]> wrote:

 IMPORTANT Please read 👀 the instructions for best results. 

Hi Gino ... I wanted to send you a quick email with a link to the
instructions [2] on how to best use CholesLo™ for maximum
results.

	Even though there are instructions on the back of the bottle, our
website has more detailed directions simply because there's more
space. Before you start taking CholesLo PLEASE READ THE INSTRUCTIONS
FOR BEST RESULTS.

	The main point to highlight here is If you are a first time user of
CholesLo™, you should first start off at a very low dose the first
2-3 days, simply to see how your body reacts. 

	What is a "little" for some people, may be a lot for others and
vice/versa. Start low, 

test only 1 or 2 capsules at a time

 and if you feel fine, then go ahead and begin using the higher
recommended dosages
, so you can see and feel the maximum benefits.

		 DETAILED USAGE INSTRUCTIONS... (CLICK IMAGE TO READ) 

		 [3] 

	On our website you'll also find
 FAQ'S, CLINICAL STUDIES, REVIEWS AND MORE. There's loads of
information to absorb !

	If you have any specific questions, please 
contact us [4].

 Warmest Regards

Dr. Sam 

		 [5] 

 No longer want to receive these emails? Unsubscribe [6].
 Health Media 3635 s fort apache rd las vegas, NV 89147

Links:
------
[1] mailto:[email-masked]
[2]
https://trk.klclick2.com/wf/click?upn=gnFrNC7qNeEjxgHGpwxvr4-2FjDSiQmoXyevaLRMf4DXKcBiQmYVNOR5Aw63gBKJ2tL21yYJ1DVDhpbIOVlF9kByCx0WjVeG4-2BTEUmlWNI0nn7Kz6sxANuKFc0gKZ3Db2LlEcYDM7nh1ee-2BlcgblxebuRTuLZ4ywK1k6cgHw80Dcmz3wL6uu37EHqNQg-2B82umv2gcoO2XYVX12QXIG4upAOoICPRWZNm5ydF0sMqlxE-2FwUiCZL4gfHofSNGz9-2FO4TW9nRh1ugwpuR9cYejPU7HJh2zPQVlLwcaQP3SscrpgjkyW8yabJEGwlRTU3vURP0f-2FHhkZSSExQz1SoiGFMk-2BRBtMl9Pi64467T1KL360niMij1xAQCJa-2FB1EQBh3MXDVOXmXrV10NheOUWYYMStckQ-3D-3D_pV8MrKWsbkHf-2F20xc2DwmJ8ZLeAHdjgAYdS-2F90vH0YpeooJ4r3scIj9ZWY4NDFdeXMI23zaOmKa7NKQq8L9wQvP-2BXvZuRIvIbV-2FdL2RLZ5iN2MbMDgr3iwRQ6z9Fde1t00OGrRRco0RLDYHp4njGq3gCRWk4dyqXQR42whJPZ6dWAP1frsKHLt15kxoHkFhb9aRmYYzx6h9Bd36doCxzohEkguzXHO4ug2YHUtUNwO2MY6jBRoEwHLhdOxI-2B9O0ZTel1RZYQuPHG9MWJ-2FCgx4y3GPQ4aC6-2FKVytJwSUSRdAFEj5pYfaiftL-2F8FMIh2LfuKHYvnMXWtJelgVf3kdfpo-2FqZpDZO-2Bd0kDmmPbFsdhjUSeu9oqUizQ5PV0O73S7Oexb9JzCjtY-2Fz-2FOd4FhRhXg-3D-3D
[3]
https://trk.klclick2.com/wf/click?upn=UPzZjb4uqHi2GlkTz4DoByKBi-2FdYzXeebu8lOkNvr1epZ-2BaxRO1CFyyfBnUYXK1xDvsxU4vSdS-2FPFf7cT9zli2gILWtGow930r1HFqQi3SuGXeJCIEyQZHkZoxuptf5W0JBIHiVNbVTCTw7RYVKCl22fiWcCvyDIf-2FTBwsJL8v3CDT1A0wkeFPKB-2B4ewRCV73eb7sT0FLXnfe2rAv6BuKZxh4L8uRQzcsVwRh1fuZyyeW1ZFthCwfpBCQWf762fpYyjE0-2BvoYCtEIKX7DR0QnxYOqB18vfgDRB-2F3tlSRFDq5zV35NrjkMTduIOsSZvkbgWeAy9vpbH-2FSklM6MczJJFDJFhwnP3KHdM06WTKtWd9Eg99VV8ZGASPg6lRpA5ysItylw-2B6rHv-2BLsd0O2a9af-2Ba-2Bgzbwck3UV1Jc2g93SIXSfbrFPc6Y-2Bnh316uyW8Sg_pV8MrKWsbkHf-2F20xc2DwmJ8ZLeAHdjgAYdS-2F90vH0YpeooJ4r3scIj9ZWY4NDFdeXMI23zaOmKa7NKQq8L9wQvP-2BXvZuRIvIbV-2FdL2RLZ5iN2MbMDgr3iwRQ6z9Fde1t00OGrRRco0RLDYHp4njGq3gCRWk4dyqXQR42whJPZ6dWAP1frsKHLt15kxoHkFhb9aRmYYzx6h9Bd36doCxzonPwzHP4VIl7WP3rTdez78kIlHq4FopNNEu2HoqvXeda0xa2f0ElPn5VF6XiQKjv-2FwpsI1pggXsQO-2FJip4buGyLBUTwtPGQ-2BxoD1o0C-2FQYXHFrIiMsfmdy1Dv7T-2Bpo7Hmu9RojcLlgYV-2FDlKYT1vov6BUBH7zChh0aXOpPpCJOAyHUoZIM12e-2Bk78ijl1HOT9A-3D-3D
[4]
https://trk.klclick2.com/wf/click?upn=UPzZjb4uqHi2GlkTz4DoB4bveQ-2F5wIlzmzJsS0eK-2B6OcR2iXKVRxd8fKZAhlLZBV3j3WeZZDRybFlvm3rWYpIF5s9x8TQf7hqQSvwPSvDH6Egtne4IlscKVnsBQrMp8QBxTomPVftjFkqAzJrdG3WnRpEG-2BNPat6ZNPX-2Fw0Tf4e7Jm5-2FraGKpl-2F4kI48BDvNjwixulvaeKTlocyvHqqSii32bUVSh9rkpY-2BbBNwL-2FUjzqUoqrpQGwWdEGOBRoyqacLom7NAaYLaFClBrcs2HJG0-2FTtXG53Jn81TPTpHfxKNFSkhX3fV-2F-2BP-2B0lcwE3z7iT0nM-2B8XwkvumFJF76D4PS-2B6FuXqHtQQq2F8yzEENhlV14ITx6JCKCmy20Qt7ZYl5_pV8MrKWsbkHf-2F20xc2DwmJ8ZLeAHdjgAYdS-2F90vH0YpeooJ4r3scIj9ZWY4NDFdeXMI23zaOmKa7NKQq8L9wQvP-2BXvZuRIvIbV-2FdL2RLZ5iN2MbMDgr3iwRQ6z9Fde1t00OGrRRco0RLDYHp4njGq3gCRWk4dyqXQR42whJPZ6dWAP1frsKHLt15kxoHkFhb9aRmYYzx6h9Bd36doCxzolBblnnNt4mm-2BOPUVnUwBpS-2FWq6MQTvjS7pBgiaadcB2NXDIKDRyzNQ1AetbCjm0jZlQ38vTvrcAKt4mdasoBTvM6OY9OF9N0rjniGqBs1lBLYlhHHqGALaY0rA1Im0kpA48HDK8-2BBmpjXPSdjnAou7uA-2FNPXweXbNZPkb2TwE-2F2LSr-2FxSv6oP0PjFeDY3SRSg-3D-3D
[5]
https://trk.klclick2.com/wf/click?upn=UPzZjb4uqHi2GlkTz4DoB2LXnhC3UDbfdqf-2B6zlDMIMaNlCsG0ms2ZqBOhW3UL-2FkmTPXSDXJHN3PQycAUkfYmAhG1fb2mPLqdalqIMFjg3mDXMLw-2BiDJnaywWLFVgoKOPQSCyzeKNw6ttgnF3JijOwSzNXDaNaQbrsPauUeHDv-2BDPBGvsEYeFK02lbEEo89WAN1y3Gx-2BmWfOsGgzYKFqJkGg0-2BUTQP1eMjcBgRxodYrX-2BkLIg11eLqSocN6kBzgSWwE-2FkB1l2OsWBf077vLJ1damtFV8ctGa-2FRjzZTGCX-2FI-2Fafk-2Fa0hbitaXSAOjRoHwAtYWHQrdcOfhw8jXzOfoNgmPIXj2YAXpeptky5bgtok-3D_pV8MrKWsbkHf-2F20xc2DwmJ8ZLeAHdjgAYdS-2F90vH0YpeooJ4r3scIj9ZWY4NDFdeXMI23zaOmKa7NKQq8L9wQvP-2BXvZuRIvIbV-2FdL2RLZ5iN2MbMDgr3iwRQ6z9Fde1t00OGrRRco0RLDYHp4njGq3gCRWk4dyqXQR42whJPZ6dWAP1frsKHLt15kxoHkFhb9aRmYYzx6h9Bd36doCxzopwWmXr6UPpBcNRHHNu3XXch5id-2BjJDDe1B4-2FRSWi5cSdyhEQywTrixsA4LtEH-2FUs8bP3TJ0nwBbhEKqQsPxP7ZfJaHbaCP3GXFYNFrf2RVA29OE0ReUtt8h0ucWPcOfqxGvC3yuDZMgnLJEXVA-2BhWlrxV6A6W5LoQIs-2Fj4-2BCPXEVB-2FmYv1dNGt6AbKgZrjzHA-3D-3D
[6]
https://trk.klclick2.com/wf/click?upn=gnFrNC7qNeEjxgHGpwxvrwthp69JmtJsRlctLK5-2BacwvLZwoyZWgKPAoexjTDHiY4MJ3El-2Fp5-2B-2FxWghAaHGTJANKDPFIWrb6vEPxMUYUmEYPVLDvgET6kjd7QgTkh4UFl6Svl6UetbrKvK-2BtsVRwxUS8i6FEpCYVLXQrkEe-2FAyYoLoTk6nEZHM-2B-2BNJvBkdYn_pV8MrKWsbkHf-2F20xc2DwmJ8ZLeAHdjgAYdS-2F90vH0YpeooJ4r3scIj9ZWY4NDFdeXMI23zaOmKa7NKQq8L9wQvP-2BXvZuRIvIbV-2FdL2RLZ5iN2MbMDgr3iwRQ6z9Fde1t00OGrRRco0RLDYHp4njGq3gCRWk4dyqXQR42whJPZ6dWAP1frsKHLt15kxoHkFhb9aRmYYzx6h9Bd36doCxzoq1lusHNOPFAKtoEZgX-2FtieB1P-2BmDaHvbzWC-2FPpvgj-2B-2BeeY124RBYvR77-2FIiv1F2B1acAnqECBmLv9eTXqZZoXRhhx1ZfI9psXUv1X7AxunSUQQigh-2FcdDU4BqhIu-2BsKYC66ZkPMejjyvRyC6v57cNcIuVmuulecN3fnV6qjofMLC4oDOU4Oy5nief6OZqzONw-3D-3D